Investigational Site 022 — Endwell, New York

Investigational Site 022 is a clinical research site located in Endwell, New York, United States 13760.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigational Site 022 has participated in 1 clinical trials.

Therapeutic areas: Clostridium Difficile Infection.

Sponsors: Sanofi Pasteur, a Sanofi Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Endwell

Browse all research sites in New York · View every site in Endwell

• Regional Clinical Research
• Meridian Clinical Research
• GSK Investigational Site
• Research Site
• Pfizer Investigational Site
• Meridian Clinical Research (Endwell-New York) - Platinum - PPDS
• Endwell Family Physicians
• Novo Nordisk Investigational Site
• Novartis Investigative Site
• Local Institution
• Endwell Family Physician
• Research Site 10001-128

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site 022?

Investigational Site 022 has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site 022 conducted?

Investigational Site 022 has 1 clinical trials on record. Their work covers Clostridium Difficile Infection.

Is Investigational Site 022 accredited by Crixeo Clinical Trials?

Investigational Site 022 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site 022?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.